Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial
Elisabeth R. Mathiesen, Amra Ciric Alibegovic, Rosa Corcoy, Fidelma Dunne, Denice S. Feig, Moshe Hod, Ting Jia, Balamurali Kalyanam, Soumitra Kar, Alexandra Kautzky‐Willer, Cassio Marchesini, Rustam Rea, Peter Damm
Topics & Concepts
MedicineInsulin detemirInsulin degludecInsulin aspartInsulinType 2 diabetesDiabetes mellitusRandomized controlled trialInternal medicineInsulin glargineEndocrinologyGestational Diabetes Research and ManagementDiabetes Management and ResearchPancreatic function and diabetes